GENEREX BIOTECHNOLOGY CORP 4
4 · GENEREX BIOTECHNOLOGY CORP · Filed Feb 16, 2016
Insider Transaction Report
Form 4
FLETCHER MARK
EVP & General Counsel
Transactions
- Exercise/Conversion
Common Stock
2016-02-16$0.00/sh+4,447,111$4,447→ 15,821,836 total - Exercise/Conversion
Common Stock Purchase Option
2016-02-16−4,447,111→ 0 totalExercise: $0.00From: 2016-02-09Exp: 2020-10-26→ Common Stock (4,447,111 underlying)